Cannabis Market - Global Forecast To 2030
商品番号 : SMB-21244
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 325 |
| 図表数 | 326 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本調査レポートは、カンナビス市場を化合物（THC優位、CBD優位、THCとCBDのバランス）、製品タイプ（花／つぼみ、オイル／チンキ、食用、外用、その他）、用途（医療用、娯楽用、工業用、栄養補助食品・ウェルネス用、化粧品・パーソナルケア用）、原料（麻、マリファナ）、地域（北米、欧州、アジア太平洋、南米、その他）別に分類しています。レポートでは、カンナビス市場の成長に影響を与える推進要因、制約、課題、機会など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの徹底的な分析により、事業概要、サービス、主要戦略、契約、パートナーシップ、合意、新サービスの開始、合併・買収、そしてカンナビス市場に関連する最近の動向に関する洞察が提供されます。カンナビスエコシステムにおける新興企業の競合分析も含まれています。さらに、この調査では、技術分析、エコシステムと市場のマッピング、特許と規制の状況などの業界固有の傾向も取り上げられています。
世界のカンナビス市場は、2025年には728億3,000万米ドルに達すると推定され、2030年には1,257億6,000万米ドルに達すると予測されています。予測期間中の年平均成長率（CAGR）は11.5%です。医療用大麻の需要増加が、この市場を牽引する大きな要因となっています。臨床研究においてTHCやCBDといったカンナビノイドの治療効果が検証されるにつれ、慢性疼痛、てんかん、多発性硬化症、不安障害、睡眠障害といった症状に対する医療用大麻を合法化する国や州が増えています。その結果、従来の医薬品に代わる植物由来の天然成分による代替品を積極的に求める患者層が増加しています。さらに、オイル、カプセル、食用、外用剤などの製品処方の進歩により、大麻ベースの治療はよりアクセスしやすく、目立たず、投与も容易になっています。様々な地域の規制当局も医療用大麻プログラムを拡大し、標準化された投与量と安全性プロファイルを備えた医薬品グレードの製品開発を奨励しています。医療用大麻の健康上の利点に関する消費者の意識の高まり、政府の支援政策、臨床採用の増加が相まって、市場の需要がさらに加速し、世界中の生産者、販売業者、医療提供者に新たな機会が生まれています。
The global market for cannabis is estimated to be valued at USD 72.83 billion in 2025 and is projected to reach USD 125.76 billion by 2030, at a CAGR of 11.5% during the forecast period. The increasing demand for medical cannabis is a major market driver. As clinical research continues to validate the therapeutic potential of cannabinoids like THC and CBD, more countries and states are legalizing medical cannabis for conditions such as chronic pain, epilepsy, multiple sclerosis, anxiety, and sleep disorders. This has led to a growing patient base actively seeking plant-based, natural alternatives to traditional pharmaceuticals. Additionally, advancements in product formulations such as oils, capsules, edibles, and topicals are making cannabis-based treatments more accessible, discreet, and easy to administer. Regulatory agencies in various regions are also expanding medical cannabis programs, encouraging the development of pharmaceutical-grade products with standardized dosing and safety profiles. Rising consumer awareness about the health benefits of medical cannabis, combined with supportive government policies and increased clinical adoption, is further accelerating market demand, creating new opportunities for producers, distributors, and healthcare providers worldwide.
“The industrial use segment is expected to be the second-fastest-growing application in the cannabis market.”
Industrial applications include textiles, with hemp being a key component. Textile-use cannabis refers to cultivating industrial hemp, a type of cannabis plant grown specifically for its strong, durable fibers rather than its psychoactive compounds. Hemp fibers are valued for their sustainability, strength, and versatility in textiles. They are commonly used to create fabrics, ropes, twines, carpets, insulation, upholstery, canvas, and eco-friendly clothing. Known for being lightweight, breathable, and resistant to pests and UV rays, hemp textiles are also biodegradable and require less water and chemicals than cotton. As demand for sustainable materials grows, hemp-based textiles are increasingly preferred in fashion, home decor, and industrial fabric applications.
“The marijuana segment holds the largest share of the cannabis market, by source.”
Marijuana refers to the dried flowers, leaves, stems, and seeds of the cannabis plant that contain psychoactive compounds, mainly tetrahydrocannabinol (THC). It is used in various forms, including dried flowers (for smoking or vaping), edibles, oils, tinctures, topicals, and concentrates. Its uses range from recreational purposes, such as relaxation and euphoria, to medical treatments for chronic pain, epilepsy, anxiety, and nausea. In March 2025, Aurora Cannabis Inc. announced a breakthrough in plant genetics, developing a powdery mildew-resistant marijuana strain through its Aurora Coast R&D program, which improves crop health, yield, and reliability for both recreational and medical marijuana cultivation.
Asia Pacific holds a significant market share in the global cannabis market.
The Asia Pacific cannabis market is gaining momentum, driven by increased awareness of medical cannabis benefits, evolving regulatory frameworks, and growing demand for plant-based wellness options. Countries like Thailand, Australia, and New Zealand have legalized medical cannabis, while others, such as Japan and South Korea, have allowed limited therapeutic use under strict regulations. The region’s expanding senior population and increasing cases of chronic conditions like cancer and arthritis are further boosting demand for cannabis-based treatments. Additionally, interest in hemp-based textiles, food, and cosmetics is growing. A notable development occurred in April 2025, when Tilray introduced Good Supply medical cannabis pastilles in Australia, marking its strategic entry into the country’s growing medical cannabis market.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the cannabis market:
- By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
- By Designation: Directors– 20%, Managers – 50%, Executives- 30%
- By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15% and Rest of the World –10%
Prominent companies in the market include Canopy Growth Corporation (Canada), Curaleaf (US), Cresco Labs (US), Green Thumb Industries (GTI) (US), Tilray Brands (US), Aurora Cannabis Inc. (Canada), Trulieve (US), MedMen (US), Blüm Holdings Inc. (US), Organigram Global (Canada), TerrAscend (US), Village Farms International Inc. (US), Verano (US), The Cronos Group (Canada), and Medical Marijuana, Inc. (US).
Other players include Vivo Cannabis Inc. (Canada), Ecofibre (Australia), Tikun Olam (Israel), Maricann Inc. (Canada), Satipharm (Canada), CannaBliss Organic LLC (US), Connected Cannabis Co. (US), Justice Cannabis Co. (US), Heritage Holding of California, LLC (US), Somai Pharmaceuticals (Portugal).
Research Coverage:
This research report categorizes the cannabis market by compound (THC-dominant, CBD-dominant, balanced THC & CBD), product type (flowers/buds, oil/tinctures, edibles, topicals, other products), application (medical use, recreational use, industrial use, nutraceutical & wellness use, cosmetics & personal care), source (hemp, marijuana), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities influencing the growth of the cannabis market. A thorough analysis of key industry players provides insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments related to the cannabis market. Competitive analysis of upcoming startups in the cannabis ecosystem is included. Additionally, industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes are also covered in this study.
Reasons to buy this report:
The report will assist market leaders and new entrants by providing estimates of revenue figures for the overall cannabis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market’s pulse and offers information on key drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (increasing cannabis demand for medicinal applications), restraints (complex regulatory structure for cannabis usage), opportunities (inorganic growth strategies adopted by US cannabis companies), and challenges (intensive water consumption and inability to maintain consistency during cannabis cultivation)
- New service launch/innovation: Detailed insights on R&D activities and service launches in the cannabis market
- Market Development: Comprehensive information about lucrative markets—the report analyzes the cannabis market across varied regions
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cannabis market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparisons, and product footprints of leading players such as Canopy Growth Corporation (Canada), Curaleaf (US), Cresco Labs (US), Green Thumb Industries (GTI) (US), Tilray Brands (US), and others in the cannabis market
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 CANNABIS MARKET SEGMENTATION AND REGIONAL SCOPE 28
1.3.2 YEARS CONSIDERED 29
1.3.3 CURRENCY CONSIDERED 30
1.4 VOLUME UNIT 30
1.5 STAKEHOLDERS 30
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 34
2.1.2.3 Breakdown of primary interviews 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.2 TOP-DOWN APPROACH 37
2.3 DATA TRIANGULATION 38
2.4 RESEARCH ASSUMPTIONS 39
2.5 RESEARCH LIMITATIONS 39
2.6 RISK ASSESSMENT 39
2.7 FACTOR ANALYSIS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 46
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CANNABIS MARKET 46
4.2 CANNABIS MARKET, BY COUNTRY 47
4.3 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE AND COUNTRY 47
4.4 CANNABIS MARKET, BY SOURCE 48
4.5 CANNABIS MARKET, BY COMPOUND TYPE 49
4.6 CANNABIS MARKET, BY APPLICATION 49
4.7 CANNABIS MARKET, BY PRODUCT TYPE 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MACROECONOMIC OUTLOOK 51
5.2.1 INCREASE IN CANNABIS PRODUCTION 51
5.2.2 RISING ANXIETY IN US ADULT POPULATION 52
5.3 MARKET DYNAMICS 54
5.3.1 DRIVERS 54
5.3.1.1 Increasing cannabis demand for medicinal applications 54
5.3.1.2 Legalization & regulatory support 55
5.3.1.3 Advancing R&D and technology as catalysts for cannabis industry growth 58
5.3.1.4 Rising global cannabis sales helping online retailers expand 59
5.3.1.5 Shift toward natural & plant-based products 60
5.3.2 RESTRAINTS 60
5.3.2.1 Regulatory complexity and lack of uniform product standards 60
5.3.2.2 Illicit market competition in California 61
5.3.2.3 Overcoming persistent social stigma and negative perceptions 61
5.3.3 OPPORTUNITIES 62
5.3.3.1 Building cannabis tourism and lifestyle experiences 62
5.3.3.2 Focus on pet wellness and veterinary cannabis 63
5.3.3.3 Rising emphasis on inorganic growth and strong potential for advancement 63
5.3.4 CHALLENGES 64
5.3.4.1 Building consumer education and awareness 64
5.3.4.2 Hiring and retaining skilled workforce 64
5.3.4.3 High water usage and challenges in achieving consistent quality 65
5.3.4.4 Advertising and marketing restrictions 65
5.4 IMPACT OF GEN AI ON CANNABIS MARKET 66
5.4.1 INTRODUCTION 66
5.4.2 CASE STUDY ANALYSIS 68
5.4.2.1 Tilray leverages digital platforms and AI-driven insights to optimize product innovation and consumer engagement 68
5.4.3 IMPACT ANALYSIS: CANNABIS MARKET 68
5.4.4 ADJACENT ECOSYSTEMS USING GENERATIVE AI 68
6 INDUSTRY TRENDS 70
6.1 INTRODUCTION 70
6.2 SUPPLY CHAIN ANALYSIS 70
6.3 VALUE CHAIN ANALYSIS 71
6.3.1 RESEARCH AND DEVELOPMENT (R&D) 72
6.3.2 RAW MATERIAL SOURCING 72
6.3.3 PRODUCTION 72
6.3.4 PACKAGING & STORAGE 72
6.3.5 DISTRIBUTION & RETAIL QUALITY CHECKS 72
6.3.6 CONSUMER FEEDBACK & REGULATORY SURVEILLANCE 73
6.4 TRADE ANALYSIS 73
6.4.1 EXPORT DATA FOR HS CODE 530210 73
6.4.2 IMPORT DATA FOR HS CODE 530210 75
6.5 TECHNOLOGY ANALYSIS 77
6.5.1 KEY TECHNOLOGIES 77
6.5.1.1 Led Glow Light 77
6.5.1.2 Nanoencapsulation 77
6.5.1.3 Artificial Intelligence and Blockchain 78
6.5.2 COMPLEMENTARY TECHNOLOGIES 78
6.5.2.1 Crop Steering 78
6.5.2.2 Vertical Farming 79
6.5.2.3 Innovative Hardware Tech Devices 79
6.5.3 ADJACENT TECHNOLOGIES 80
6.5.3.1 IOT Automation 80
6.5.3.2 Genetic Engineering 81
6.6 PRICING ANALYSIS 81
6.6.1 INDICATIVE SELLING PRICE TREND, BY KEY PLAYER 81
6.6.2 INDICATIVE SELLING PRICE TREND, BY SOURCE 82
6.6.3 INDICATIVE SELLING PRICE TREND, BY REGION 82
6.7 ECOSYSTEM ANALYSIS 83
6.7.1 SUPPLY SIDE 83
6.7.2 DEMAND SIDE 83
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85
6.9 PATENT ANALYSIS 86
6.10 KEY CONFERENCES AND EVENTS, 2025–2026 91
6.11 TARIFFS AND REGULATORY LANDSCAPE 91
6.11.1 TARIFFS RELATED TO INDUSTRIAL CANNABIS 91
6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
6.11.3 REGULATORY FRAMEWORK 94
6.11.3.1 North America 94
6.11.3.1.1 US 94
6.11.3.1.2 Canada 95
6.11.3.1.3 Mexico 96
6.11.3.2 Europe 97
6.11.3.2.1 UK 97
6.11.3.2.2 Germany 97
6.11.3.3 Asia Pacific 98
6.11.3.3.1 China 98
6.11.3.3.2 India 98
6.11.3.4 South America 99
6.11.3.4.1 Brazil 99
6.11.3.5 Rest of the World 99
6.11.3.5.1 South Africa 99
6.12 IMPACT OF 2025 US TARIFFS—CANNABIS MARKET 100
6.12.1 INTRODUCTION 100
6.12.2 KEY TARIFF RATES 100
6.12.3 DISRUPTIONS IN CANNABIS PRODUCTS 101
6.12.4 PRICE IMPACT ANALYSIS 102
6.12.5 IMPACT ON COUNTRIES/REGIONS 103
6.12.5.1 US 103
6.12.5.2 Europe 103
6.12.5.3 China 104
6.12.6 IMPACT ON END-USE INDUSTRIES 104
6.13 PORTER’S FIVE FORCES ANALYSIS 105
6.13.1 THREAT OF NEW ENTRANTS 106
6.13.2 THREAT OF SUBSTITUTES 106
6.13.3 BARGAINING POWER OF SUPPLIERS 107
6.13.4 BARGAINING POWER OF BUYERS 107
6.13.5 INTENSITY OF COMPETITIVE RIVALRY 107
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
6.14.2 BUYING CRITERIA 109
6.15 CASE STUDY ANALYSIS 110
6.15.1 CASE STUDY 1: AURORA’S STRATEGIC ENTRY INTO INDUSTRIAL HEMP 110
6.15.2 CASE STUDY 2: TILRAY BUILDS GERMAN MEDICAL CANNABIS SUPPLY CHAIN 110
6.15.3 CASE STUDY 3: DEMECAN LAUNCHES LIVE ROSIN UNDER GOOD MANUFACTURING PRACTICE (GMP) 110
6.16 INVESTMENT AND FUNDING SCENARIO 111
7 CANNABIS MARKET, BY COMPOUND TYPE 112
7.1 INTRODUCTION 113
7.2 THC-DOMINANT 114
7.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET 114
7.3 CBD-DOMINANT 115
7.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET 115
7.4 BALANCED THC & CBD 116
7.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC 116
8 CANNABIS MARKET, BY PRODUCT TYPE 118
8.1 INTRODUCTION 119
8.2 FLOWERS/BUDS 120
8.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE ROLL DOMAIN 120
8.3 OILS/TINCTURES 122
8.3.1 PARTNERSHIPS AND EXPANSION OF CANNABIS OILS TO DRIVE MARKET 122
8.4 EDIBLES 123
8.4.1 RISING INTEREST OF FOOD & BEVERAGE COMPANIES IN CANNABIS-INFUSED EDIBLES TO DRIVE MARKET 123
8.5 TOPICALS 125
8.5.1 TOPICALS WITNESSING INCREASED DEMAND IN SKINCARE INDUSTRY 125
8.6 OTHER PRODUCT TYPES 126
9 CANNABIS MARKET, BY APPLICATION 128
9.1 INTRODUCTION 129
9.2 MEDICINAL USE 130
9.2.1 RISING USE IN TREATMENT DRIVES DEMAND FOR MEDICAL CANNABIS 130
9.2.1.1 Pain management 131
9.2.1.2 Neurological health management 131
9.2.1.3 Mental health management 131
9.2.1.4 Other medical purposes 131
9.3 RECREATIONAL USE 132
9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS
TO BOOST MARKET GROWTH 132
9.4 INDUSTRIAL USE 134
9.4.1 EXPANDING INDUSTRIAL APPLICATIONS AND SUSTAINABLE POTENTIAL
OF CANNABIS TO DRIVE MARKET 134
9.4.1.1 Textiles 135
9.4.1.2 Paper 135
9.4.1.3 Food & beverages 136
9.4.1.4 Biodegradable materials 136
9.5 NUTRACEUTICAL & WELLNESS USE 137
9.5.1 GROWTH IN CBD-INFUSED NUTRACEUTICALS AND WELLNESS PRODUCTS TO DRIVE MARKET 137
9.6 COSMETIC & PERSONAL CARE USE 139
9.6.1 EXPANDING APPLICATIONS OF CBD-INFUSED SKINCARE AND PERSONAL CARE PRODUCTS TO DRIVE MARKET 139
10 CANNABIS MARKET, BY SOURCE 141
10.1 INTRODUCTION 142
10.2 HEMP 143
10.2.1 EXPANDING INDUSTRIAL APPLICATIONS AND WELLNESS INNOVATIONS TO DRIVE HEMP MARKET 143
10.3 MARIJUANA 144
10.3.1 DIVERSIFICATION OF MARIJUANA APPLICATIONS TO DRIVE MARKET 144
11 CANNABIS MARKET, BY REGION 147
11.1 INTRODUCTION 148
11.2 NORTH AMERICA 150
11.2.1 US 154
11.2.1.1 Technological advancements & precision cultivation to drive market 154
11.2.2 CANADA 155
11.2.2.1 Strong presence of leading market players to fuel growth 155
11.2.3 MEXICO 156
11.2.3.1 Emerging domestic brands and startups to propel market 156
11.3 EUROPE 157
11.3.1 GERMANY 162
11.3.1.1 Increased physician willingness to prescribe medical cannabis drives market growth 162
11.3.2 UK 163
11.3.2.1 Growing investment and M&A activities driving the market 163
11.3.3 FRANCE 164
11.3.3.1 Government reimbursement and structured healthcare integration to support growth 164
11.3.4 SPAIN 165
11.3.4.1 Favorable climate and infrastructure for low-cost cultivation driving market 165
11.3.5 ITALY 166
11.3.5.1 Expansion of authorized pharmacies for medical cannabis distribution to drive market 166
11.3.6 REST OF EUROPE 167
11.4 ASIA PACIFIC 168
11.4.1 CHINA 171
11.4.1.1 Strong focus on industrial hemp production to strengthen growth prospects 171
11.4.2 INDIA 172
11.4.2.1 Rising domestic demand for natural and plant-based remedies to drive market 172
11.4.3 JAPAN 173
11.4.3.1 Public and institutional support for industrial hemp driving market growth 173
11.4.4 AUSTRALIA & NEW ZEALAND 174
11.4.4.1 Rising investment from global cannabis companies to drive market 174
11.4.5 THAILAND 175
11.4.5.1 Growing wellness and cannabis tourism sector to fuel market growth 175
11.4.6 REST OF ASIA PACIFIC 176
11.5 SOUTH AMERICA 177
11.5.1 BRAZIL 180
11.5.1.1 Strengthening domestic innovation and strategic partnerships to drive market 180
11.5.2 ARGENTINA 181
11.5.2.1 Establishment of ARICCAME and regulatory realignment to support market growth 181
11.5.3 REST OF SOUTH AMERICA 182
11.6 REST OF THE WORLD 183
11.6.1 MIDDLE EAST 186
11.6.1.1 Evolving public perception and patient advocacy driving the market 186
11.6.2 AFRICA 187
11.6.2.1 Development of cannabis research and innovation to drive market 187
12 COMPETITIVE LANDSCAPE 189
12.1 OVERVIEW 189
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 190
12.3 REVENUE ANALYSIS, 2019–2023 192
12.4 MARKET SHARE ANALYSIS, 2024 192
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 195
12.5.1 STARS 195
12.5.2 EMERGING LEADERS 196
12.5.3 PERVASIVE PLAYERS 196
12.5.4 PARTICIPANTS 196
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 197
12.5.5.1 Company footprint 197
12.5.5.2 Regional footprint 198
12.5.5.3 Product type footprint 199
12.5.5.4 Application footprint 200
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 201
12.6.1 PROGRESSIVE COMPANIES 201
12.6.2 RESPONSIVE COMPANIES 201
12.6.3 DYNAMIC COMPANIES 201
12.6.4 STARTING BLOCKS 201
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 203
12.6.5.1 Detailed list of key startups/SMEs 203
12.6.5.2 Competitive benchmarking of key startups/SMEs 204
12.7 COMPANY VALUATION AND FINANCIAL METRICS 206
12.8 BRAND/SERVICE COMPARATIVE ANALYSIS 208
12.9 COMPETITIVE SCENARIO 209
12.9.1 PRODUCT/SERVICE LAUNCHES AND ENHANCEMENTS 209
12.9.2 DEALS 211
12.9.3 EXPANSIONS 212
12.9.4 OTHER DEVELOPMENTS 213
13 COMPANY PROFILES 215
13.1 KEY PLAYERS 215
13.1.1 CANOPY GROWTH CORPORATION 215
13.1.1.1 Business overview 215
13.1.1.2 Products/Solutions/Services offered 216
13.1.1.3 Recent developments 218
13.1.1.3.1 Product/Service launches 218
13.1.1.3.2 Deals 220
13.1.1.3.3 Expansions 221
13.1.1.4 MnM view 221
13.1.1.4.1 Right to win 221
13.1.1.4.2 Strategic choices 221
13.1.1.4.3 Weaknesses and competitive threats 222
13.1.2 CURALEAF, INC. 223
13.1.2.1 Business overview 223
13.1.2.2 Products/Solutions/Services offered 224
13.1.2.3 Recent developments 225
13.1.2.3.1 Product/Service launches 225
13.1.2.3.2 Deals 226
13.1.2.3.3 Expansions 227
13.1.2.3.4 Other developments 228
13.1.2.4 MnM view 229
13.1.2.4.1 Right to win 229
13.1.2.4.2 Strategic choices 229
13.1.2.4.3 Weaknesses and competitive threats 229
13.1.3 GREEN THUMB INDUSTRIES 230
13.1.3.1 Business overview 230
13.1.3.2 Products/Solutions/Services offered 231
13.1.3.3 Recent developments 232
13.1.3.3.1 Product/Service launches 232
13.1.3.3.2 Deals 233
13.1.3.3.3 Expansions 234
13.1.3.4 MnM view 234
13.1.3.4.1 Right to win 234
13.1.3.4.2 Strategic choices 234
13.1.3.4.3 Weaknesses and competitive threats 235
13.1.4 TILRAY BRANDS, INC. 236
13.1.4.1 Business overview 236
13.1.4.2 Products/Solutions/Services offered 237
13.1.4.3 Recent developments 239
13.1.4.3.1 Product/Service launches 239
13.1.4.3.2 Deals 241
13.1.4.3.3 Other developments 241
13.1.4.4 MnM view 242
13.1.4.4.1 Right to win 242
13.1.4.4.2 Strategic choices 242
13.1.4.4.3 Weaknesses and competitive threats 242
13.1.5 TRULIEVE 243
13.1.5.1 Business overview 243
13.1.5.2 Products/Solutions/Services offered 244
13.1.5.3 Recent developments 244
13.1.5.3.1 Product/Service launches 244
13.1.5.3.2 Deals 245
13.1.5.4 MnM view 246
13.1.5.4.1 Right to win 246
13.1.5.4.2 Strategic choices 247
13.1.5.4.3 Weaknesses and competitive threats 247
13.1.6 CRESCO LABS 248
13.1.6.1 Business overview 248
13.1.6.2 Products/Solutions/Services offered 249
13.1.6.3 Recent developments 250
13.1.6.3.1 Product/Service launches 250
13.1.6.3.2 Deals 250
13.1.6.3.3 Other developments 251
13.1.6.4 MnM view 251
13.1.7 AURORA CANNABIS INC. 252
13.1.7.1 Business overview 252
13.1.7.2 Products/Solutions/Services offered 253
13.1.7.3 Recent developments 254
13.1.7.3.1 Product/Service Launches 254
13.1.7.3.2 Deals 256
13.1.7.3.3 Expansions 257
13.1.7.4 MnM view 258
13.1.8 ORGANIGRAM GLOBAL 259
13.1.8.1 Business overview 259
13.1.8.2 Products/Solutions/Services offered 260
13.1.8.3 Recent developments 261
13.1.8.3.1 Product/Service Launches 261
13.1.8.3.2 Deals 262
13.1.8.3.3 Other developments 264
13.1.8.4 MnM view 264
13.1.9 TERRASCEND 265
13.1.9.1 Business overview 265
13.1.9.2 Products/Solutions/Services offered 266
13.1.9.3 Recent developments 267
13.1.9.3.1 Deals 267
13.1.9.3.2 Expansions 268
13.1.9.4 MnM view 269
13.1.10 BLÜM HOLDINGS INC. 270
13.1.10.1 Business overview 270
13.1.10.2 Products/Solutions/Services offered 271
13.1.10.3 Recent developments 271
13.1.10.3.1 Deals 271
13.1.10.3.2 Other developments 272
13.1.10.4 MnM view 273
13.1.11 VILLAGE FARMS INTERNATIONAL INC. 274
13.1.11.1 Business overview 274
13.1.11.2 Products/Solutions/Services offered 275
13.1.11.3 Recent developments 276
13.1.11.3.1 Product/Service launches 276
13.1.11.3.2 Deals 277
13.1.11.3.3 Other developments 278
13.1.11.4 MnM view 278
13.1.12 VERANO 279
13.1.12.1 Business overview 279
13.1.12.2 Products/Solutions/Services offered 280
13.1.12.3 Recent developments 281
13.1.12.3.1 Product/Service launches 281
13.1.12.3.2 Deals 282
13.1.12.3.3 Expansions 283
13.1.12.4 MnM view 284
13.1.13 THE CRONOS GROUP 285
13.1.13.1 Business overview 285
13.1.13.2 Products/Solutions/Services offered 286
13.1.13.3 Recent developments 287
13.1.13.3.1 Product/Service launches 287
13.1.13.3.2 Deals 289
13.1.13.3.3 Other developments 289
13.1.13.4 MnM view 290
13.1.14 MEDICAL MARIJUANA, INC. 291
13.1.14.1 Business overview 291
13.1.14.2 Products/Solutions/Services offered 292
13.1.14.3 Recent developments 293
13.1.14.3.1 Product/Service launches 293
13.1.14.3.2 Deals 294
13.1.14.4 MnM view 294
13.1.15 MEDIPHARM LABS 295
13.1.15.1 Business overview 295
13.1.15.2 Products/Solutions/Services offered 296
13.1.15.3 Recent developments 298
13.1.15.3.1 Product/Service launches 298
13.1.15.3.2 Deals 298
13.1.15.4 MnM view 299
13.2 OTHER PLAYERS 300
13.2.1 CANNBIT 300
13.2.1.1 Business overview 300
13.2.1.2 Products/Solutions/Services offered 301
13.2.1.3 MnM view 302
13.2.2 MARICANN INC. 303
13.2.2.1 Business overview 303
13.2.2.2 Products/Solutions/Services offered 303
13.2.2.3 MnM view 304
13.2.3 CANNABLISS ORGANIC LLC. 305
13.2.3.1 Business overview 305
13.2.3.2 Products/Solutions/Services offered 305
13.2.3.3 MnM view 305
13.2.4 CONNECTED CANNABIS CO. 306
13.2.4.1 Business overview 306
13.2.4.2 Products/Solutions/Services offered 306
13.2.4.3 MnM view 308
13.2.5 TOWER THREE LLC 309
13.2.5.1 Business overview 309
13.2.5.2 Products/Solutions/Services offered 309
13.2.5.3 MnM view 309
13.2.6 SATIPHARM 310
13.2.7 JUSTICE CANNABIS CO. 311
13.2.8 HERITAGE CANNABIS 312
13.2.9 SOMAÍ PHARMACEUTICALS LTD. 312
13.2.10 HENRY’S ORIGINAL 313
14 ADJACENT & RELATED MARKETS 314
14.1 INTRODUCTION 314
14.2 LIMITATIONS 314
14.3 INDUSTRIAL HEMP MARKET 314
14.3.1 MARKET DEFINITION 314
14.3.2 MARKET OVERVIEW 314
14.4 CANNABIS TESTING MARKET 316
14.4.1 MARKET DEFINITION 316
14.4.2 MARKET OVERVIEW 316
15 APPENDIX 318
15.1 DISCUSSION GUIDE 318
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 321
15.3 CUSTOMIZATION OPTIONS 323
15.4 RELATED REPORTS 323
15.5 AUTHOR DETAILS 324
LIST OF TABLES
TABLE 1 INCLUSIONS AND EXCLUSIONS 29
TABLE 2 USD EXCHANGE RATES CONSIDERED, 2020–2024 30
TABLE 3 CANNABIS MARKET SHARE SNAPSHOT, 2025 VS. 2030 (USD MILLION) 41
TABLE 4 INORGANIC GROWTH STRATEGIES ADOPTED BY KEY PLAYERS 63
TABLE 5 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES,
2021–2024 (USD THOUSAND) 74
TABLE 6 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2020–2024 (KG) 74
TABLE 7 IMPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES,
2021–2024 (USD THOUSAND) 76
TABLE 8 IMPORT SCENARIO OF HS CODE 530210 FOR TOP 10 COUNTRIES,
2021–2024 (KG) 76
TABLE 9 AVERAGE SELLING PRICE TREND OF CANNABIS FLOWERS,
BY KEY PLAYER, 2025 (USD/G) 82
TABLE 10 INDICATIVE SELLING PRICE TREND, BY SOURCE, 2025 (USD/KG) 82
TABLE 11 INDICATIVE SELLING PRICE TREND, BY REGION, 2025 (USD/KG) 83
TABLE 12 ROLE OF COMPANIES IN ECOSYSTEM 84
TABLE 13 PATENTS PERTAINING TO CANNABIS MARKET AND RELATED PATENTS,
2016–2024 87
TABLE 14 CANNABIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 91
TABLE 15 CANNABIS MARKET: TARIFF FOR HS CODE 530210, 2024 91
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 20 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES 100
TABLE 22 EXPECTED IMPACT ON PRODUCTS UNDER RELEVANT HS CODES 102
TABLE 23 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: CANNABIS PRODUCTS 104
TABLE 24 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 105
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE
TEST TYPE (%) 109
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES 109
TABLE 27 CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 113
TABLE 28 CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 113
TABLE 29 THC-DOMINANT CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 114
TABLE 30 THC-DOMINANT CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 115
TABLE 31 CBD-DOMINANT CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 116
TABLE 32 CBD-DOMINANT CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 116
TABLE 33 BALANCED THC & CBD CANNABIS MARKET, BY REGION,
2020–2024 (USD MILLION) 117
TABLE 34 BALANCED THC & CBD CANNABIS MARKET, BY REGION,
2025–2030 (USD MILLION) 117
TABLE 35 CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 119
TABLE 36 CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 120
TABLE 37 FLOWERS/BUDS: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 121
TABLE 38 FLOWERS/BUDS: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 122
TABLE 39 OILS/TINCTURES: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 123
TABLE 40 OILS/TINCTURES: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 123
TABLE 41 EDIBLES: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 124
TABLE 42 EDIBLES: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 124
TABLE 43 TOPICALS: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 125
TABLE 44 TOPICALS: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 126
TABLE 45 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION,
2020–2024 (USD MILLION) 127
TABLE 46 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION,
2025–2030 (USD MILLION) 127
TABLE 47 CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 129
TABLE 49 CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 130
TABLE 50 MEDICINAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 132
TABLE 51 MEDICINAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 132
TABLE 52 RECREATIONAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 134
TABLE 53 RECREATIONAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 134
TABLE 54 INDUSTRIAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 137
TABLE 55 INDUSTRIAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 137
TABLE 56 NUTRACEUTICAL & WELLNESS USE: CANNABIS MARKET, BY REGION,
2020–2024 (USD MILLION) 138
TABLE 57 NUTRACEUTICAL & WELLNESS USE: CANNABIS MARKET, BY REGION,
2025–2030 (USD MILLION) 138
TABLE 58 COSMETIC & PERSONAL CARE USE: CANNABIS MARKET, BY REGION,
2020–2024 (USD MILLION) 139
TABLE 59 COSMETIC & PERSONAL CARE USE: CANNABIS MARKET, BY REGION,
2025–2030 (USD MILLION) 140
TABLE 60 CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 142
TABLE 61 CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 142
TABLE 62 HEMP: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 144
TABLE 63 HEMP: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 144
TABLE 64 MARIJUANA: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 145
TABLE 65 MARIJUANA: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 146
TABLE 66 CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 149
TABLE 67 CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 149
TABLE 68 CANNABIS MARKET, BY REGION, 2020–2024 (TONS) 149
TABLE 69 CANNABIS MARKET, BY REGION, 2025–2030 (TONS) 150
TABLE 70 NORTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 151
TABLE 71 NORTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 152
TABLE 72 NORTH AMERICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 152
TABLE 73 NORTH AMERICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 152
TABLE 74 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE,
2020–2024 (USD MILLION) 152
TABLE 75 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE,
2025–2030 (USD MILLION) 153
TABLE 76 NORTH AMERICA: CANNABIS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 153
TABLE 77 NORTH AMERICA: CANNABIS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 153
TABLE 78 NORTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE,
2020–2024 (USD MILLION) 154
TABLE 79 NORTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 154
TABLE 80 US: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 155
TABLE 81 US: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 155
TABLE 82 CANADA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 156
TABLE 83 CANADA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 156
TABLE 84 MEXICO: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 157
TABLE 85 MEXICO: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 157
TABLE 86 EUROPE: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 159
TABLE 87 EUROPE: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 159
TABLE 88 EUROPE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 159
TABLE 89 EUROPE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 160
TABLE 90 EUROPE: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 160
TABLE 91 EUROPE: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 160
TABLE 92 EUROPE: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 160
TABLE 93 EUROPE: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 161
TABLE 94 EUROPE: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 161
TABLE 95 EUROPE: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 161
TABLE 96 GERMANY: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 162
TABLE 97 GERMANY: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 162
TABLE 98 UK: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 163
TABLE 99 UK: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 163
TABLE 100 FRANCE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 164
TABLE 101 FRANCE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 164
TABLE 102 SPAIN: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 165
TABLE 103 SPAIN: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 165
TABLE 104 ITALY: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 166
TABLE 105 ITALY: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 166
TABLE 106 REST OF EUROPE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 167
TABLE 107 REST OF EUROPE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 168
TABLE 108 ASIA PACIFIC: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 168
TABLE 109 ASIA PACIFIC: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 169
TABLE 110 ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 169
TABLE 111 ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 169
TABLE 112 ASIA PACIFIC: CANNABIS MARKET, BY COMPOUND TYPE,
2020–2024 (USD MILLION) 169
TABLE 113 ASIA PACIFIC: CANNABIS MARKET, BY COMPOUND TYPE,
2025–2030 (USD MILLION) 170
TABLE 114 ASIA PACIFIC: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 170
TABLE 115 ASIA PACIFIC: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 170
TABLE 116 ASIA PACIFIC: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 171
TABLE 117 ASIA PACIFIC: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 171
TABLE 118 CHINA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 172
TABLE 119 CHINA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 172
TABLE 120 INDIA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 173
TABLE 121 INDIA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 173
TABLE 122 JAPAN: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 174
TABLE 123 JAPAN: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 174
TABLE 124 AUSTRALIA & NEW ZEALAND: CANNABIS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 175
TABLE 125 AUSTRALIA & NEW ZEALAND: CANNABIS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 175
TABLE 126 THAILAND: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 176
TABLE 127 THAILAND: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 176
TABLE 128 REST OF ASIA PACIFIC: CANNABIS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 177
TABLE 129 REST OF ASIA PACIFIC: CANNABIS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 177
TABLE 130 SOUTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 178
TABLE 131 SOUTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 178
TABLE 132 SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 178
TABLE 133 SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 178
TABLE 134 SOUTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE,
2020–2024 (USD MILLION) 179
TABLE 135 SOUTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE,
2025–2030 (USD MILLION) 179
TABLE 136 SOUTH AMERICA: CANNABIS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 179
TABLE 137 SOUTH AMERICA: CANNABIS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 179
TABLE 138 SOUTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE,
2020–2024 (USD MILLION) 180
TABLE 139 SOUTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 180
TABLE 140 BRAZIL: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 181
TABLE 141 BRAZIL: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 181
TABLE 142 ARGENTINA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 182
TABLE 143 ARGENTINA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 182
TABLE 144 REST OF SOUTH AMERICA: CANNABIS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 183
TABLE 145 REST OF SOUTH AMERICA: CANNABIS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 183
TABLE 146 REST OF THE WORLD: CANNABIS MARKET, BY REGION,
2020–2024 (USD MILLION) 184
TABLE 147 REST OF THE WORLD: CANNABIS MARKET, BY REGION,
2025–2030 (USD MILLION) 184
TABLE 148 REST OF THE WORLD: CANNABIS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 184
TABLE 149 REST OF THE WORLD: CANNABIS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 184
TABLE 150 REST OF THE WORLD: CANNABIS MARKET, BY COMPOUND TYPE,
2020–2024 (USD MILLION) 184
TABLE 151 REST OF THE WORLD: CANNABIS MARKET, BY COMPOUND TYPE,
2025–2030 (USD MILLION) 185
TABLE 152 REST OF THE WORLD: CANNABIS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 185
TABLE 153 REST OF THE WORLD: CANNABIS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 185
TABLE 154 REST OF THE WORLD: CANNABIS MARKET, BY PRODUCT TYPE,
2020–2024 (USD MILLION) 186
TABLE 155 REST OF THE WORLD: CANNABIS MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 186
TABLE 156 MIDDLE EAST: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 187
TABLE 157 MIDDLE EAST: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 187
TABLE 158 AFRICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 188
TABLE 159 AFRICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 188
TABLE 160 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CANNABIS MARKET 190
TABLE 161 CANNABIS MARKET: DEGREE OF COMPETITION 193
TABLE 162 CANNABIS MARKET: REGIONAL FOOTPRINT 198
TABLE 163 CANNABIS MARKET: PRODUCT TYPE FOOTPRINT 199
TABLE 164 CANNABIS MARKET: APPLICATION FOOTPRINT 200
TABLE 165 CANNABIS MARKET: KEY STARTUPS/SMES 203
TABLE 166 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 (1/2) 204
TABLE 167 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 (2/2) 205
TABLE 168 CANNABIS MARKET: PRODUCT/SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2021–MAY 2025 209
TABLE 169 CANNABIS MARKET: DEALS, JANUARY 2021– MAY 2025 211
TABLE 170 CANNABIS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025 212
TABLE 171 CANNABIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021– MAY 2025 213
TABLE 172 CANOPY GROWTH CORPORATION: COMPANY OVERVIEW 215
TABLE 173 CANOPY GROWTH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
TABLE 174 CANOPY GROWTH CORPORATION: PRODUCT/SERVICE LAUNCHES 218
TABLE 175 CANOPY GROWTH CORPORATION: DEALS 220
TABLE 176 CANOPY GROWTH CORPORATION: EXPANSIONS 221
TABLE 177 CURALEAF, INC.: COMPANY OVERVIEW 223
TABLE 178 CURALEAF, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224
TABLE 179 CURALEAF, INC.: PRODUCT/SERVICE LAUNCHES 225
TABLE 180 CURALEAF, INC.: DEALS 226
TABLE 181 CURALEAF, INC.: EXPANSIONS 227
TABLE 182 CURALEAF, INC.: OTHER DEVELOPMENTS 228
TABLE 183 GREEN THUMB INDUSTRIES: COMPANY OVERVIEW 230
TABLE 184 GREEN THUMB INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 231
TABLE 185 GREEN THUMB INDUSTRIES: PRODUCT/SERVICE LAUNCHES 232
TABLE 186 GREEN THUMB INDUSTRIES: DEALS 233
TABLE 187 GREEN THUMB INDUSTRIES: EXPANSIONS 234
TABLE 188 TILRAY BRANDS, INC.: COMPANY OVERVIEW 236
TABLE 189 TILRAY BRANDS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237
TABLE 190 TILRAY BRANDS, INC.: PRODUCT/SERVICE LAUNCHES 239
TABLE 191 TILRAY BRANDS, INC.: DEALS 241
TABLE 192 TILRAY BRANDS, INC.: OTHER DEVELOPMENTS 241
TABLE 193 TRULIEVE: COMPANY OVERVIEW 243
TABLE 194 TRULIEVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244
TABLE 195 TRULIEVE: PRODUCT/SERVICE LAUNCHES 244
TABLE 196 TRULIEVE: DEALS 245
TABLE 197 CRESCO LABS: COMPANY OVERVIEW 248
TABLE 198 CRESCO LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249
TABLE 199 CRESCO LABS: PRODUCT/SERVICE LAUNCHES 250
TABLE 200 CRESCO LABS: DEALS 250
TABLE 201 CRESCO LABS: OTHER DEVELOPMENTS 251
TABLE 202 AURORA CANNABIS INC.: COMPANY OVERVIEW 252
TABLE 203 AURORA CANNABIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 253
TABLE 204 AURORA CANNABIS INC.: PRODUCT/SERVICE LAUNCHES 254
TABLE 205 AURORA CANNABIS INC.: DEALS 256
TABLE 206 AURORA CANNABIS INC.: EXPANSIONS 257
TABLE 207 ORGANIGRAM GLOBAL: COMPANY OVERVIEW 259
TABLE 208 ORGANIGRAM GLOBAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260
TABLE 209 ORGANIGRAM GLOBAL: PRODUCT/SERVICE LAUNCHES 261
TABLE 210 ORGANIGRAM GLOBAL: DEALS 262
TABLE 211 ORGANIGRAM GLOBAL: OTHER DEVELOPMENTS 264
TABLE 212 TERRASCEND: COMPANY OVERVIEW 265
TABLE 213 TERRASCEND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 266
TABLE 214 TERRASCEND: DEALS 267
TABLE 215 TERRASCEND: EXPANSIONS 268
TABLE 216 BLÜM HOLDINGS INC.: COMPANY OVERVIEW 270
TABLE 217 BLÜM HOLDINGS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 271
TABLE 218 BLÜM HOLDINGS INC.: DEALS 271
TABLE 219 BLÜM HOLDINGS INC.: OTHER DEVELOPMENTS 272
TABLE 220 VILLAGE FARMS INTERNATIONAL INC.: COMPANY OVERVIEW 274
TABLE 221 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 222 VILLAGE FARMS INTERNATIONAL INC.: PRODUCT/SERVICE LAUNCHES 276
TABLE 223 VILLAGE FARMS INTERNATIONAL INC.: DEALS 277
TABLE 224 VILLAGE FARMS INTERNATIONAL INC.: OTHER DEVELOPMENTS 278
TABLE 225 VERANO: COMPANY OVERVIEW 279
TABLE 226 VERANO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 280
TABLE 227 VERANO: PRODUCT/SERVICE LAUNCHES 281
TABLE 228 VERANO: DEALS 282
TABLE 229 VERANO: EXPANSIONS 283
TABLE 230 THE CRONOS GROUP: COMPANY OVERVIEW 285
TABLE 231 THE CRONOS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286
TABLE 232 THE CRONOS GROUP: PRODUCT/SERVICE LAUNCHES 287
TABLE 233 THE CRONOS GROUP: DEALS 289
TABLE 234 THE CRONOS GROUP: OTHER DEVELOPMENTS 289
TABLE 235 MEDICAL MARIJUANA, INC.: COMPANY OVERVIEW 291
TABLE 236 MEDICAL MARIJUANA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292
TABLE 237 MEDICAL MARIJUANA, INC.: PRODUCT/SERVICE LAUNCHES 293
TABLE 238 MEDICAL MARIJUANA, INC.: DEALS 294
TABLE 239 MEDIPHARM LABS: COMPANY OVERVIEW 295
TABLE 240 MEDIPHARM LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 296
TABLE 241 MEDIPHARM LABS: PRODUCT/SERVICE LAUNCHES 298
TABLE 242 MEDIPHARM LABS: DEALS 298
TABLE 243 CANNBIT: COMPANY OVERVIEW 300
TABLE 244 CANNBIT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 301
TABLE 245 MARICANN INC.: COMPANY OVERVIEW 303
TABLE 246 MARICANN INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 303
TABLE 247 CANNABLISS ORGANIC LLC.: COMPANY OVERVIEW 305
TABLE 248 CANNABLISS ORGANIC LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 305
TABLE 249 CONNECTED CANNABIS CO.: COMPANY OVERVIEW 306
TABLE 250 CONNECTED CANNABIS CO.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 306
TABLE 251 TOWER THREE LLC: COMPANY OVERVIEW 309
TABLE 252 TOWER THREE LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 309
TABLE 253 ADJACENT MARKETS 314
TABLE 254 INDUSTRIAL HEMP MARKET, BY TYPE, 2019–2023 (USD MILLION) 315
TABLE 255 INDUSTRIAL HEMP MARKET, BY TYPE, 2024–2029 (USD MILLION) 315
TABLE 256 INDUSTRIAL HEMP MARKET, BY TYPE, 2019–2023 (KT) 315
TABLE 257 INDUSTRIAL HEMP MARKET, BY TYPE, 2024–2029 (KT) 316
TABLE 258 CANNABIS TESTING MARKET, BY PRODUCT & SOFTWARE,
2022–2029 (USD MILLION) 317
LIST OF FIGURES
FIGURE 1 CANNABIS MARKET: RESEARCH DESIGN 32
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE)—COLLECTIVE REVENUE OF ALL PRODUCTS 36
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (DEMAND SIDE) 36
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 (TOP-DOWN) 37
FIGURE 5 CANNABIS MARKET: DATA TRIANGULATION 38
FIGURE 6 THC-DOMINANT CANNABIS TO HOLD LARGEST MARKET SHARE DURING
FORECAST PERIOD 42
FIGURE 7 FLOWERS/BUDS TO HOLD LARGEST MARKET SHARE 43
FIGURE 8 RECREATIONAL USE APPLICATION TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD 43
FIGURE 9 MARIJUANA TO DOMINATE CANNABIS MARKET, BY SOURCE, DURING
FORECAST PERIOD 44
FIGURE 10 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45
FIGURE 11 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES 46
FIGURE 12 US TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 47
FIGURE 13 US AND THC-DOMINANT SEGMENT TO ACCOUNT FOR SIGNIFICANT
SHARES IN 2024 47
FIGURE 14 MARIJUANA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48
FIGURE 15 THC-DOMINANT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 49
FIGURE 16 RECREATIONAL USE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 49
FIGURE 17 FLOWERS/BUDS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 50
FIGURE 18 LEADING CANNABIS-PRODUCING COUNTRIES, 2023 (USD MILLION) 52
FIGURE 19 SURVEY-INDICATED ANXIETY LEVELS AMONG US ADULTS (%) 52
FIGURE 20 TOP ANXIETY TRIGGERS AMONG US ADULTS IN 2024 53
FIGURE 21 CANNABIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
FIGURE 22 EUROPE: USERS ENTERING CANNABIS TREATMENT, 2023 55
FIGURE 23 GLOBAL REGULATORY OVERVIEW INDICATING LEGALITY OF CANNABIS, 2024 57
FIGURE 24 ADOPTION OF GEN AI IN CANNABIS MARKET 67
FIGURE 25 CANNABIS MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 26 CANNABIS MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 27 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES,
2021–2024 (USD THOUSAND) 73
FIGURE 28 IMPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES,
2021–2024 (USD THOUSAND) 75
FIGURE 29 CANNABIS MARKET: ECOSYSTEM 84
FIGURE 30 CANNABIS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85
FIGURE 31 PATENTS APPLIED AND GRANTED, 2015–2024 86
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS AND RELATED MARKETS, 2015–2024 87
FIGURE 33 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 106
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR TOP THREE APPLICATIONS 108
FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES 109
FIGURE 36 CANNABIS MARKET: INVESTMENT AND FUNDING SCENARIO, 2021–2025 111
FIGURE 37 CANNABIS MARKET, BY COMPOUND TYPE, 2025 VS. 2030 (USD MILLION) 113
FIGURE 38 CANNABIS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 119
FIGURE 39 CANNABIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 129
FIGURE 40 CANNABIS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 142
FIGURE 41 GERMANY TO RECORD FASTEST GROWTH FROM 2025 TO 2030 148
FIGURE 42 NORTH AMERICA: MARKET SNAPSHOT 151
FIGURE 43 EUROPE: MARKET SNAPSHOT 158
FIGURE 44 REVENUE ANALYSIS FOR KEY PLAYERS, 2019–2023 192
FIGURE 45 CANNABIS MARKET SHARE ANALYSIS, 2024 193
FIGURE 46 CANNABIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 196
FIGURE 47 CANNABIS MARKET: COMPANY FOOTPRINT 197
FIGURE 48 CANNABIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 202
FIGURE 49 COMPANY VALUATION OF KEY VENDORS 206
FIGURE 50 FINANCIAL METRICS OF KEY VENDORS 206
FIGURE 51 YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 207
FIGURE 52 CANNABIS MARKET: BRAND/SERVICE COMPARISON 208
FIGURE 53 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT 216
FIGURE 54 CURALEAF, INC.: COMPANY SNAPSHOT 223
FIGURE 55 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT 230
FIGURE 56 TILRAY BRANDS, INC.: COMPANY SNAPSHOT 237
FIGURE 57 TRULIEVE: COMPANY SNAPSHOT 243
FIGURE 58 CRESCO LABS: COMPANY SNAPSHOT 248
FIGURE 59 AURORA CANNABIS INC.: COMPANY SNAPSHOT 252
FIGURE 60 ORGANIGRAM GLOBAL: COMPANY SNAPSHOT 260
FIGURE 61 TERRASCEND: COMPANY SNAPSHOT 265
FIGURE 62 BLÜM HOLDINGS INC.: COMPANY SNAPSHOT 270
FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT 275
FIGURE 64 VERANO: COMPANY SNAPSHOT 280
FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT 286
FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT 291
FIGURE 67 MEDIPHARM LABS: COMPANY SNAPSHOT 296
FIGURE 68 CANNBIT: COMPANY SNAPSHOT 301
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11